These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
355 related items for PubMed ID: 31339561
1. Prognostic factors and patterns of failure after surgery for T4 rectal cancer in the beyond total mesorectal excision era. Peacock O, Waters PS, Bressel M, Lynch AC, Wakeman C, Eglinton T, Koh CE, Lee PJ, Austin KK, Warrier SK, Solomon MJ, Frizelle FA, Heriot AG. Br J Surg; 2019 Nov; 106(12):1685-1696. PubMed ID: 31339561 [Abstract] [Full Text] [Related]
8. Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes. Leroy J, Jamali F, Forbes L, Smith M, Rubino F, Mutter D, Marescaux J. Surg Endosc; 2004 Feb; 18(2):281-9. PubMed ID: 14691716 [Abstract] [Full Text] [Related]
9. Recurrence and survival after mesorectal excision for rectal cancer. Bülow S, Christensen IJ, Harling H, Kronborg O, Fenger C, Nielsen HJ, Danish TME Study Group, RANX05 Colorectal Cancer Study Group. Br J Surg; 2003 Aug; 90(8):974-80. PubMed ID: 12905551 [Abstract] [Full Text] [Related]
10. Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry. Jörgren F, Lydrup ML, Buchwald P. Br J Surg; 2020 Dec; 107(13):1818-1825. PubMed ID: 32484249 [Abstract] [Full Text] [Related]
11. Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery. Borstlap WA, Coeymans TJ, Tanis PJ, Marijnen CA, Cunningham C, Bemelman WA, Tuynman JB. Br J Surg; 2016 Aug; 103(9):1105-16. PubMed ID: 27302385 [Abstract] [Full Text] [Related]
16. Survival after pelvic exenteration for T4 rectal cancer. Kusters M, Austin KK, Solomon MJ, Lee PJ, Nieuwenhuijzen GA, Rutten HJ. Br J Surg; 2015 Jan; 102(1):125-31. PubMed ID: 25451182 [Abstract] [Full Text] [Related]
17. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. Perez RO, Habr-Gama A, Lynn PB, São Julião GP, Bianchi R, Proscurshim I, Gama-Rodrigues J. Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274 [Abstract] [Full Text] [Related]
20. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE). Kim CW, Kang BM, Kim IY, Kim JY, Park SJ, Park WC, Bae KB, Bae BN, Baek SK, Baik SH, Son GM, Lee YS, Lee SH. BMC Cancer; 2018 May 08; 18(1):538. PubMed ID: 29739356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]